Novel regulators of vitamin D action and metabolism: Lessons learned at the Los Angeles zoo.
We undertook an investigation of an outbreak of rachitic bone disease in the Emperor Tamarin New World primate colony at the Los Angeles Zoo in the mid-1980s. The disease phenotype resembled that observed in humans with an inactivating mutation of the vitamin D receptor (VDR), hypocalcemia, high 1,25-dihydroxyvitamin D (1,25-(OH)(2)D) levels, and rickets in rapidly growing adolescent primates. In contrast to the human disease, the New World primate VDR was functionally normal in all respects. The proximate cause of vitamin D hormone resistance in New World primates was determined to be the constitutive overexpression of a heterogeneous nuclear ribonucleoprotein in the A family which we coined the vitamin D response element binding protein (VDRE-BP). VDRE-BP competed in trans with the VDR-retinoid X receptor (RXR) for binding to the vitamin D response element. VDRE-BP-legislated resistance to 1,25-(OH)(2)D was antagonized (i.e., compensated) by another set of constitutively overexpressed proteins, the hsp-70-related intracellular vitamin D binding proteins (IDBPs). IDBPs, present but expressed at much lower levels in Old World primates including man, exhibited a high capacity for 25-hydroxylated vitamin D metabolites and functioned to traffic vitamin Ds to specific intracellular destinations to promote their action and metabolism.
Adams
J S
JS
Burns and Allen Research Institute, Division of Endocrinology, Cedars-Sinai Medical Center, UCLA School of Medicine, Los Angeles, California, USA.
Chen
H
H
Chun
R F
RF
Nguyen
L
L
Wu
S
S
Ren
S Y
SY
Barsony
J
J
Gacad
M A
MA
D000818:Animals; D004351:Drug Resistance; D018840:HSP70 Heat-Shock Proteins / Q000378:metabolism; D006370:Heliotherapy; D034441:Heterogeneous-Nuclear Ribonucleoproteins / Q000096:biosynthesis / Q000235:genetics; D006801:Humans; D008992:Monkey Diseases / Q000235:genetics*; D018168:Receptors, Retinoic Acid / Q000378:metabolism; D047488:Retinoid X Receptors; D012279:Rickets / Q000097:blood / Q000235:genetics* / Q000503:physiopathology* / Q000628:therapy; D012452:Saguinus / Q000235:genetics*; D014157:Transcription Factors / Q000378:metabolism; D014807:Vitamin D / Q000031:analogs & derivatives* / Q000097:blood* / Q000494:pharmacology; D030181:Vitamin D Response Element / Q000502:physiology; D014809:Vitamin D-Binding Protein / Q000235:genetics / Q000378:metabolism*
D018840:HSP70 Heat-Shock Proteins; D034441:Heterogeneous-Nuclear Ribonucleoproteins; D018168:Receptors, Retinoic Acid; D047488:Retinoid X Receptors; D014157:Transcription Factors; D014809:Vitamin D-Binding Protein; D014807:Vitamin D; C097949:1,25-dihydroxyvitamin D